PAUL BOWER M.D. NPI 1144540386

NPI Details

Paul Bower, M.D. is an urology in Port Saint Lucie, FL with 15 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. Paul Bower, M.D. NPI is 1144540386. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: BOSTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2010

The provider's business location address is:

1941 SE PORT ST LUCIE BLVD
PORT SAINT LUCIE, FL
ZIP 34952-535
Phone: (772) 340-6777

The NPI 1144540386 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, onabotulinumtoxina, 1 unit (HCPCS:J0585)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Urinalysis, manual test (HCPCS:81002)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Biopsy of prostate gland (HCPCS:55700)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope (HCPCS:52601)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Exam with injections of chemical for destruction of bladder using an endoscope (HCPCS:52287)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Destruction and/or removal of large growth of bladder using an endoscope (HCPCS:52240)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm (HCPCS:52235)
• Diagnostic exam of bladder, urethra, and ureter or kidney using an endoscope (HCPCS:52351)
• Hernia repair (minimally invasive) (HCPCS:NAN16)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 6/10/2010 and was last updated on 5/29/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: